Could a common bladder pill help save eyesight?
NCT ID NCT07305298
Summary
This study is testing if a medication called Mirabegron, usually used for overactive bladder, can help slow the progression of dry age-related macular degeneration (AMD), a leading cause of vision loss. Researchers will compare it to another bladder drug (Solifenacin) in 312 older adults who have both conditions. Participants will take one of the pills daily for a year while their eye health is monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Federico II
Naples, Italy
Conditions
Explore the condition pages connected to this study.